USD
+$0.00
(+0.00%
)At Close (As of Sep 3, 2025)
$5.15M
Market Cap
-
P/E Ratio
-1.7
EPS
$21.96
52 Week High
$1.41
52 Week Low
LIFE SCIENCES
Sector
Field | Value (USD) |
---|---|
Gross Profit | $139K |
Total Revenue | $144K |
Cost Of Revenue | $5K |
Costof Goods And Services Sold | $5K |
Operating Income | -$13M |
Selling General And Administrative | $7.7M |
Research And Development | $5M |
Operating Expenses | $13M |
Investment Income Net | - |
Net Interest Income | $130K |
Interest Income | $140K |
Interest Expense | $10K |
Non Interest Income | - |
Other Non Operating Income | - |
Depreciation | - |
Depreciation And Amortization | $266K |
Income Before Tax | -$2.5M |
Income Tax Expense | $2K |
Interest And Debt Expense | - |
Net Income From Continuing Operations | -$2.5M |
Comprehensive Income Net Of Tax | - |
Ebit | -$2.5M |
Ebitda | -$2.2M |
Net Income | -$2.5M |
Field | Value (USD) |
---|---|
Total Assets | $15M |
Total Current Assets | $12M |
Cash And Cash Equivalents At Carrying Value | $11M |
Cash And Short Term Investments | $11M |
Inventory | $0 |
Current Net Receivables | $30K |
Total Non Current Assets | $2.5M |
Property Plant Equipment | - |
Accumulated Depreciation Amortization Ppe | - |
Intangible Assets | - |
Intangible Assets Excluding Goodwill | - |
Goodwill | - |
Investments | - |
Long Term Investments | - |
Short Term Investments | - |
Other Current Assets | $789K |
Other Non Current Assets | - |
Total Liabilities | $4.2M |
Total Current Liabilities | $3.7M |
Current Accounts Payable | $1.6M |
Deferred Revenue | - |
Current Debt | - |
Short Term Debt | $521K |
Total Non Current Liabilities | $421K |
Capital Lease Obligations | $942K |
Long Term Debt | - |
Current Long Term Debt | - |
Long Term Debt Noncurrent | - |
Short Long Term Debt Total | $942K |
Other Current Liabilities | $1.6M |
Other Non Current Liabilities | - |
Total Shareholder Equity | $10M |
Treasury Stock | - |
Retained Earnings | -$342M |
Common Stock | $2K |
Common Stock Shares Outstanding | $1.5M |
Field | Value (USD) |
---|---|
Operating Cashflow | -$9.5M |
Payments For Operating Activities | - |
Proceeds From Operating Activities | - |
Change In Operating Liabilities | - |
Change In Operating Assets | - |
Depreciation Depletion And Amortization | $266K |
Capital Expenditures | $13K |
Change In Receivables | - |
Change In Inventory | -$501K |
Profit Loss | - |
Cashflow From Investment | $9M |
Cashflow From Financing | $8.8M |
Proceeds From Repayments Of Short Term Debt | - |
Payments For Repurchase Of Common Stock | - |
Payments For Repurchase Of Equity | - |
Payments For Repurchase Of Preferred Stock | - |
Dividend Payout | - |
Dividend Payout Common Stock | - |
Dividend Payout Preferred Stock | - |
Proceeds From Issuance Of Common Stock | - |
Proceeds From Issuance Of Long Term Debt And Capital Securities Net | - |
Proceeds From Issuance Of Preferred Stock | - |
Proceeds From Repurchase Of Equity | - |
Proceeds From Sale Of Treasury Stock | - |
Change In Cash And Cash Equivalents | - |
Change In Exchange Rate | - |
Net Income | -$2.5M |
Field | Value (USD) |
---|---|
Gross Profit | $139K |
Total Revenue | $144K |
Cost Of Revenue | $5K |
Costof Goods And Services Sold | $5K |
Operating Income | -$13M |
Selling General And Administrative | $7.7M |
Research And Development | $5M |
Operating Expenses | $13M |
Investment Income Net | - |
Net Interest Income | $130K |
Interest Income | $140K |
Interest Expense | $10K |
Non Interest Income | - |
Other Non Operating Income | - |
Depreciation | - |
Depreciation And Amortization | $266K |
Income Before Tax | -$2.5M |
Income Tax Expense | $2K |
Interest And Debt Expense | - |
Net Income From Continuing Operations | -$2.5M |
Comprehensive Income Net Of Tax | - |
Ebit | -$2.5M |
Ebitda | -$2.2M |
Net Income | -$2.5M |
Sector: LIFE SCIENCES
Industry: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
VivoSim Labs, Inc., a biotechnology company, focuses on developing 3D tissues that recapitulate key aspects of human disease. The company is headquartered in San Diego, California.